-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update
Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update
Roche Holding AG (OTCMKTS:RHHBY – Get Rating) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 2,820,200 shares, a growth of 34.4% from the August 31st total of 2,097,800 shares. Based on an average daily trading volume, of 2,367,600 shares, the short-interest ratio is currently 1.2 days.
Roche Stock Down 1.2 %
Shares of RHHBY stock traded down $0.49 on Friday, reaching $40.62. The company's stock had a trading volume of 1,986,635 shares, compared to its average volume of 1,930,656. The company has a current ratio of 0.93, a quick ratio of 0.73 and a debt-to-equity ratio of 0.57. Roche has a 12-month low of $37.88 and a 12-month high of $53.86. The stock's 50 day simple moving average is $41.30 and its 200-day simple moving average is $43.42.
Get Roche alerts:Institutional Investors Weigh In On Roche
A number of large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors increased its holdings in shares of Roche by 15.0% in the second quarter. Captrust Financial Advisors now owns 46,398 shares of the company's stock worth $1,934,000 after buying an additional 6,041 shares during the period. Madison Asset Management LLC bought a new stake in shares of Roche in the second quarter worth about $2,097,000. Boston Common Asset Management LLC grew its stake in shares of Roche by 8.6% in the second quarter. Boston Common Asset Management LLC now owns 651,564 shares of the company's stock worth $27,100,000 after purchasing an additional 51,537 shares during the last quarter. Altrius Capital Management Inc bought a new stake in shares of Roche in the second quarter worth about $4,037,000. Finally, Tevis Investment Management grew its stake in shares of Roche by 46.8% in the second quarter. Tevis Investment Management now owns 17,626 shares of the company's stock worth $731,000 after purchasing an additional 5,621 shares during the last quarter. Hedge funds and other institutional investors own 0.23% of the company's stock.
Wall Street Analysts Forecast Growth
RHHBY has been the topic of a number of research reports. Cowen reduced their price objective on Roche from $58.00 to $48.00 and set an "outperform" rating on the stock in a research report on Monday, June 27th. Deutsche Bank Aktiengesellschaft reduced their price objective on Roche from CHF 350 to CHF 325 and set a "hold" rating on the stock in a research report on Friday, July 22nd. Berenberg Bank upgraded Roche from a "hold" rating to a "buy" rating in a research report on Wednesday, September 14th. Barclays reduced their price target on Roche from CHF 450 to CHF 400 and set an "overweight" rating on the stock in a research report on Tuesday, July 19th. Finally, Credit Suisse Group upgraded Roche from a "neutral" rating to an "outperform" rating in a research report on Thursday, September 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $260.14.Roche Company Profile
(Get Rating)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation.
See Also
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
Roche Holding AG (OTCMKTS:RHHBY – Get Rating) saw a large growth in short interest in September. As of September 15th, there was short interest totalling 2,820,200 shares, a growth of 34.4% from the August 31st total of 2,097,800 shares. Based on an average daily trading volume, of 2,367,600 shares, the short-interest ratio is currently 1.2 days.
罗氏控股公司(Roche Holding AG)(场外交易代码:RHHBY-GET Rating)9月份空头股数股价大幅增长。截至9月15日,空头股数共有2,820,200股,较8月31日的2,097,800股增长34.4%。以日均成交量2,367,600股计算,目前短息比率为1.2天。
Roche Stock Down 1.2 %
罗氏股价下跌1.2%
Shares of RHHBY stock traded down $0.49 on Friday, reaching $40.62. The company's stock had a trading volume of 1,986,635 shares, compared to its average volume of 1,930,656. The company has a current ratio of 0.93, a quick ratio of 0.73 and a debt-to-equity ratio of 0.57. Roche has a 12-month low of $37.88 and a 12-month high of $53.86. The stock's 50 day simple moving average is $41.30 and its 200-day simple moving average is $43.42.
上周五,RHHBY股价下跌0.49美元,至40.62美元。该公司股票的成交量为1,986,635股,而其平均成交量为1,930,656股。该公司的流动比率为0.93,速动比率为0.73,债务权益比率为0.57。罗氏的12个月低点为37.88美元,12个月高位为53.86美元。该股的50日简单移动均线切入位为41.30美元,200日简单移动均线切入位为43.42美元。
Institutional Investors Weigh In On Roche
机构投资者参与罗氏
A number of large investors have recently added to or reduced their stakes in the company. Captrust Financial Advisors increased its holdings in shares of Roche by 15.0% in the second quarter. Captrust Financial Advisors now owns 46,398 shares of the company's stock worth $1,934,000 after buying an additional 6,041 shares during the period. Madison Asset Management LLC bought a new stake in shares of Roche in the second quarter worth about $2,097,000. Boston Common Asset Management LLC grew its stake in shares of Roche by 8.6% in the second quarter. Boston Common Asset Management LLC now owns 651,564 shares of the company's stock worth $27,100,000 after purchasing an additional 51,537 shares during the last quarter. Altrius Capital Management Inc bought a new stake in shares of Roche in the second quarter worth about $4,037,000. Finally, Tevis Investment Management grew its stake in shares of Roche by 46.8% in the second quarter. Tevis Investment Management now owns 17,626 shares of the company's stock worth $731,000 after purchasing an additional 5,621 shares during the last quarter. Hedge funds and other institutional investors own 0.23% of the company's stock.
一些大型投资者最近增持或减持了该公司的股份。CapTrust Financial Advisors在第二季度增持了15.0%的罗氏股票。CapTrust Financial Advisors目前持有46,398股该公司股票,价值1,934,000美元,在此期间又购买了6,041股。麦迪逊资产管理公司(Madison Asset Management LLC)在第二季度购买了价值约2,097,000美元的罗氏新股。波士顿共同资产管理有限责任公司在第二季度增持了8.6%的罗氏股票。波士顿共同资产管理公司(Boston Common Asset Management LLC)在上个季度额外购买了51,537股后,目前拥有651,564股该公司股票,价值27,10万美元。Altrius Capital Management Inc.在第二季度购买了价值约4,037,000美元的罗氏新股。最后,Tevis投资管理公司在第二季度增持了46.8%的罗氏股票。Tevis投资管理公司在上个季度又购买了5621股,现在拥有17626股该公司股票,价值73.1万美元。对冲基金和其他机构投资者持有该公司0.23%的股票。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Roche Company Profile
罗氏公司简介
(Get Rating)
(获取评级)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation.
罗氏控股公司在瑞士、德国、美国、奥地利、荷兰、英国、法国、比利时和国际上从事制药和诊断业务。该公司提供治疗肿瘤学、神经科学、感染学、免疫学、心血管和新陈代谢、眼科和呼吸系统以及贫血、癌症、皮肤科、血友病、炎症和自身免疫、神经科和移植的药物。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Roche (RHHBY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- Declining Profits Challenge the CarMax Value Proposition
- 免费获取StockNews.com关于罗氏的研究报告(RHHBY)
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat:回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 让Paychex股票为您努力工作
- 利润下降对CarMax价值主张的挑战
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
接受《罗氏日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对罗氏和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧